TNF Pharmaceuticals ( (TNFA) ) has released a notification of late filing.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
TNF Pharmaceuticals has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The company cites the need for additional time to complete and finalize its financial statements as the primary reason for the delay. TNF Pharmaceuticals expects to file the report within five calendar days following the prescribed due date. The company does not anticipate any significant changes in its financial results compared to the previous year. TNF Pharmaceuticals is committed to maintaining compliance and has ensured all other required reports have been filed. The notification was signed by Joshua Silverman, Director, on August 14, 2025.
More about TNF Pharmaceuticals
Average Trading Volume: 34,539,732
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.56M
Learn more about TNFA stock on TipRanks’ Stock Analysis page.